Astrotech Reports First Quarter of Fiscal Year 2018 Financial Results
Astrotech Corporation (NASDAQ: ASTC) reported its financial results for the first quarter of fiscal year 2018 ended
September 30, 2017.
“In the first quarter, our subsidiary 1st Detect achieved a significant milestone toward the deployment of explosives
trace detector systems with the Transportation Security Administration (TSA),” said Thomas B. Pickens III, Chairman and CEO of
Astrotech Corporation. “In September, we announced that we entered a Cooperative Research and Development Agreement (CRADA) with
the Department of Homeland Security (DHS) Science and Technology Directorate (S&T) Transportation Security Laboratory (TSL) for
the development, testing, and evaluation of our TRACER 1000 MS-ETD system. Using TSL’s credible, unbiased and objective
Developmental Test and Evaluation (DT&E) process, TSL and 1st Detect will examine ways to improve trace detection
capabilities in support of transportation security.
“1st Detect’s healthcare product for breath analysis, the BreathDetect 1000, continues to make progress in
pre-clinical trials with cystic fibrosis patients at UT Health San Antonio (UTHSA). Our partnership with UTHSA is initially
focusing on identifying hospital-acquired pneumonia (HAP), of which there are over 150,000 cases reported annually. By enabling
detection of HAP and reducing the wait time for a proper diagnosis from several days to within minutes, the BreathDetect 1000 can
significantly enhance the physician’s ability to administer optimal antibiotics–reducing the liability exposure for hospitals while
saving lives.
“In addition, Astral Images was selected by a post-production house for the digital conversion of a feature-length film that
included defect correction using our Astral Color ICE proprietary technology. Astral was chosen for its ability to detect defects
in automation while reducing costs and turnaround time. Astral continues to be positioned to lead the conversion of digital film as
global adoption of 4K HDR televisions ramps up and demand for 4K HDR content and services grows,” Mr. Pickens concluded.
First Quarter Fiscal Year 2018 Financial Highlights
Revenue, costs of goods sold, SG&A, and R&D are expected to continue to fluctuate based on the timing of
projects.
1st Detect’s income from research-based, fixed-price, government-related subcontract agreements ended during the last
quarter of fiscal 2017. Therefore, there was no revenue or gross profit generated in the first quarter of fiscal 2018, compared to
$1.0 million and $275 thousand, respectively, in the first quarter of fiscal 2017.
Cash and investments at September 30, 2017 were $11.6 million, and there was no debt.
About Astrotech
Astrotech Corporation (NASDAQ: ASTC) is an innovative science and technology company that invents, acquires, and commercializes
technological innovations sourced from research institutions, laboratories, universities, and internally, and then funds, manages,
and builds proprietary, scalable start-up companies for profitable divestiture to market leaders to maximize shareholder value.
Sourced from Oak Ridge Laboratory’s chemical analyzer research, 1 st Detect develops, manufactures, and sells chemical analyzers for use in
the security, defense, healthcare, food and beverage, and environmental markets. Sourced from decades of image research from the
laboratories of IBM and Kodak, Astral Images sells film-to-digital image enhancement, defect removal and color correction software, and post
processing services providing economically feasible conversion of television and feature 35mm and 16mm films to the new 4K
ultra-high definition (UHD), high-dynamic range (HDR) format necessary for the new generation of digital distribution. Sourced from
NASA’s extensive microgravity research, Astrogenetix is applying a fast-track, on-orbit discovery platform using the International Space Station to
develop vaccines and other therapeutics. Demonstrating its entrepreneurial strategy, Astrotech management sold its state-of-the-art
satellite servicing operations to Lockheed Martin in August 2014. Astrotech has operations throughout Texas and is headquartered in
Austin. For information, please visit www.astrotechcorp.com .
This press release contains forward-looking statements that are made pursuant to the Safe Harbor provisions of the Private
Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks, trends, and uncertainties that
could cause actual results to be materially different from the forward-looking statement. These factors include, but are not
limited to, whether we can successfully develop our proprietary technologies and whether the market will accept our products and
services, as well as other risk factors and business considerations described in the Company’s Securities and Exchange Commission
filings including the annual report on Form 10-K. Any forward-looking statements in this document should be evaluated in light of
these important risk factors. The Company assumes no obligation to update these forward-looking statements.
|
|
|
|
|
|
|
|
| ASTROTECH CORPORATION AND SUBSIDIARIES |
| Condensed Consolidated Statements of Operations and Comprehensive
Loss |
|
(In thousands, except per share data)
|
|
(Unaudited)
|
|
|
|
|
|
|
|
Three Months Ended
September 30, |
|
|
|
2017 |
|
|
2016 |
| Revenue |
|
|
$ |
— |
|
|
|
$ |
1,006 |
|
| Cost of revenue |
|
|
|
— |
|
|
|
|
731 |
|
| Gross profit |
|
|
|
— |
|
|
|
|
275 |
|
| Operating expenses: |
|
|
|
|
|
|
| Selling, general and administrative |
|
|
|
1,407 |
|
|
|
|
2,548 |
|
| Research and development |
|
|
|
1,669 |
|
|
|
|
1,292 |
|
| Total operating expenses |
|
|
|
3,076 |
|
|
|
|
3,840 |
|
| Loss from operations |
|
|
|
(3,076 |
) |
|
|
|
(3,565 |
) |
| Interest and other income, net |
|
|
|
70 |
|
|
|
|
98 |
|
| Loss before income taxes |
|
|
|
(3,006 |
) |
|
|
|
(3,467 |
) |
| Income tax benefit |
|
|
|
— |
|
|
|
|
— |
|
| Net loss |
|
|
|
(3,006 |
) |
|
|
|
(3,467 |
) |
| Less: Net loss attributable to noncontrolling interest |
|
|
|
— |
|
|
|
|
(52 |
) |
| Net loss attributable to Astrotech Corporation |
|
|
$ |
(3,006 |
) |
|
|
$ |
(3,415 |
) |
|
|
|
|
|
|
|
| Weighted average common shares outstanding: |
|
|
|
|
|
|
| Basic and diluted |
|
|
|
4,057 |
|
|
|
|
4,126 |
|
|
|
|
|
|
|
|
| Basic and diluted net loss per common share: |
|
|
|
|
|
|
| Net loss attributable to Astrotech Corporation |
|
|
$ |
(0.15 |
) |
|
|
$ |
(0.17 |
) |
|
|
|
|
|
|
|
| Other comprehensive loss, net of tax: |
|
|
|
|
|
|
| Net loss attributable to Astrotech Corporation |
|
|
$ |
(3,006 |
) |
|
|
$ |
(3,415 |
) |
| Available-for-sale securities: |
|
|
|
|
|
|
| Net unrealized gain |
|
|
$ |
1 |
|
|
|
$ |
41 |
|
| Reclassification adjustment for realized loss |
|
|
|
1 |
|
|
|
|
— |
|
| Total comprehensive loss |
|
|
$ |
(3,004 |
) |
|
|
$ |
(3,374 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ASTROTECH CORPORATION AND SUBSIDIARIES |
| Condensed Consolidated Balance Sheets |
|
(In thousands, except share data)
|
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
September 30,
2017
|
|
|
June 30,
2017 |
| Assets |
|
|
|
|
|
|
| Current assets |
|
|
|
|
|
|
| Cash and cash equivalents |
|
|
$ |
95 |
|
|
|
$ |
2,184 |
|
| Short-term investments |
|
|
|
10,062 |
|
|
|
|
10,900 |
|
| Accounts receivable, net of allowance |
|
|
|
80 |
|
|
|
|
146 |
|
| Inventory, net |
|
|
|
132 |
|
|
|
|
166 |
|
| Prepaid expenses and other current assets |
|
|
|
246 |
|
|
|
|
269 |
|
| Total current assets |
|
|
|
10,615 |
|
|
|
|
13,665 |
|
| Property and equipment, net |
|
|
|
3,001 |
|
|
|
|
3,180 |
|
| Long-term investments |
|
|
|
1,428 |
|
|
|
|
1,990 |
|
| Other assets, net |
|
|
|
81 |
|
|
|
|
— |
|
| Total assets |
|
|
$ |
15,125 |
|
|
|
$ |
18,835 |
|
|
|
|
|
|
|
|
| Liabilities and stockholders’ equity |
|
|
|
|
|
|
| Current liabilities |
|
|
|
|
|
|
| Accounts payable |
|
|
$ |
200 |
|
|
|
$ |
259 |
|
| Payroll related accruals |
|
|
|
414 |
|
|
|
|
907 |
|
| Accrued liabilities and other |
|
|
|
382 |
|
|
|
|
641 |
|
| Income tax payable |
|
|
|
2 |
|
|
|
|
2 |
|
| Total current liabilities |
|
|
|
998 |
|
|
|
|
1,809 |
|
| Other liabilities |
|
|
|
242 |
|
|
|
|
256 |
|
| Total liabilities |
|
|
|
1,240 |
|
|
|
|
2,065 |
|
|
|
|
|
|
|
|
| Stockholders’ equity |
|
|
|
|
|
|
| Preferred stock, no par value, convertible, 2,500,000 shares authorized; no shares
issued and outstanding, at September 30, 2017 and June 30, 2017, respectively |
|
|
|
— |
|
|
|
|
— |
|
| Common stock, no par value, 15,000,000 shares authorized; 4,506,473 and 4,508,509
shares issued at September 30, 2017 and June 30, 2017, respectively; 4,108,573 and 4,111,281 shares outstanding at September
30, 2017 and June 30, 2017, respectively |
|
|
|
190,437 |
|
|
|
|
190,382 |
|
| Treasury stock, 397,936 and 397,228 shares at cost at September 30, 2017 and June 30,
2017, respectively |
|
|
|
(4,124 |
) |
|
|
|
(4,121 |
) |
| Additional paid-in capital |
|
|
|
1,550 |
|
|
|
|
1,483 |
|
| Accumulated deficit |
|
|
|
(173,919 |
) |
|
|
|
(170,913 |
) |
| Accumulated other comprehensive loss |
|
|
|
(59 |
) |
|
|
|
(61 |
) |
| Total stockholders’ equity |
|
|
|
13,885 |
|
|
|
|
16,770 |
|
| Total liabilities and stockholders’ equity |
|
|
$ |
15,125 |
|
|
|
$ |
18,835 |
|
Company Contact:
Astrotech Corporation
Eric Stober, 512-485-9530
Chief Financial Officer
or
IR Contact:
LHA Investor Relations
Cathy Mattison and Kirsten Chapman, 415-433-3777
ir@astrotechcorp.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20171108005311/en/